Periprocedural management of new oral anticoagulants in patients undergoing atrial fibrillation ablation.
about
Novel oral anticoagulants in non-valvular atrial fibrillation.Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.Efficacy and safety of rivaroxaban compared with vitamin K antagonists for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.Oral anticoagulant use around the time of atrial fibrillation ablation: a review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxis.Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Soc
P2860
Periprocedural management of new oral anticoagulants in patients undergoing atrial fibrillation ablation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Periprocedural management of n ...... atrial fibrillation ablation.
@en
type
label
Periprocedural management of n ...... atrial fibrillation ablation.
@en
prefLabel
Periprocedural management of n ...... atrial fibrillation ablation.
@en
P2093
P1433
P1476
Periprocedural management of n ...... atrial fibrillation ablation.
@en
P2093
Allan C Skanes
Atul Verma
Jeffrey I Weitz
Jeffrey S Healey
P304
P356
10.1161/CIRCULATIONAHA.113.005376
P407
P577
2014-04-01T00:00:00Z